CORT Sean Maduck sells $1.6M worth of shares
Dec 06, 2025, 11:35 AM
0.00%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
Sean Maduck sold 20,000 shares of CORT on 1 December at $79.52 per share, worth a total of $1.6M. They now own 7,904 CORT shares, or a 72% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.